Alonzo Thomas D insider trades: Salix Pharmaceuticals (SLXP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alonzo reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 22, 2014 | SLXP | ↓ Sell | 11,530 | $110.89 | $1.3M | Direct | Apr 24, 2014 (2d) |
| Jan 10, 2014 | SLXP | ↓ Sell | 12,050 | $91.83 | $1.1M | Direct | Jan 14, 2014 (4d) |
| Apr 8, 2013 | SLXP | ↓ Sell | 6,186 | $49.57 | $307K | Direct | Apr 10, 2013 (2d) |
| Jun 8, 2012 | SLXP | ↓ Sell | 7,000 | $51.63 | $361K | Direct | Jun 12, 2012 (4d) |
| Jun 8, 2012 | SLXP | ↓ Sell | 2,550 | $51.63 | $132K | By LLC | Jun 12, 2012 (4d) |
| Dec 6, 2011 | SLXP | ↓ Sell | 4,700 | $44.43 | $209K | Direct | Dec 8, 2011 (2d) |
| Aug 11, 2011 | SLXP | ↑ Buy | 580 | $29.77 | $17K | By Trust | Aug 11, 2011 (0d) |
| Aug 11, 2011 | SLXP | ↑ Buy | 110 | $29.45 | $3K | Direct | Aug 11, 2011 (0d) |
| Dec 1, 2010 | SLXP | ↑ Buy | 500 | $44.80 | $22K | By Trust | Dec 3, 2010 (2d) |
| Oct 7, 2010 | SLXP | ↑ Buy | 260 | $38.00 | $10K | By LP | Oct 12, 2010 (5d) |
| May 13, 2009 | SLXP | ↓ Sell | 22,500 | $10.09 | $227K | Direct | May 13, 2009 (0d) |
| Jul 3, 2007 | SLXP | ↓ Sell | 3,129 | $12.30 | $38K | Direct | Jul 6, 2007 (3d) |
| Nov 13, 2006 | SLXP | ↓ Sell | 1,200 | $13.18 | $16K | By LLC | Nov 15, 2006 (2d) |
| May 8, 2006 | SLXP | ↑ Buy | 5,000 | $13.01 | $65K | By Wife | May 10, 2006 (2d) |
| May 8, 2006 | SLXP | ↑ Buy | 1,000 | $13.03 | $13K | By Son | May 10, 2006 (2d) |
| May 8, 2006 | SLXP | ↑ Buy | 900 | $13.01 | $12K | Direct | May 10, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alonzo Thomas D's insider trades
Alonzo Thomas D is Acting President and CEO at Salix Pharmaceuticals (SLXP). Since May 8, 2006, Alonzo has reported 7 open-market purchases worth $143K and 9 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), shares withheld for taxes (7 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.